Page last updated: 2024-09-04

atazanavir sulfate and Diarrhea

atazanavir sulfate has been researched along with Diarrhea in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Anastos, K; Aouizerat, BE; Bacchetti, P; French, AL; Gange, S; Greenblatt, RM; Gustafson, DR; Huang, Y; Hysi, PG; Kassaye, S; Nowicki, MJ; Tamraz, B	1
Andrade-Villanueva, J; Cheng, AK; Chuck, SL; Clotet, B; Clumeck, N; Lamarca, A; Liu, YP; Margot, N; Molina, JM; Zhong, L	1

Trials

1 trial(s) available for atazanavir sulfate and Diarrhea

Article	Year
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study. The Lancet. Infectious diseases, 2012, Volume: 12, Issue:1 Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; Aspartate Aminotransferases; Atazanavir Sulfate; CD4 Lymphocyte Count; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Male; Middle Aged; Oligopeptides; Pyridines; Pyrrolidinones; Quinolones; Raltegravir Potassium; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load	2012

Article

Year

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study.

The Lancet. Infectious diseases, 2012, Volume: 12, Issue:1

Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; Aspartate Aminotransferases; Atazanavir Sulfate; CD4 Lymphocyte Count; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Male; Middle Aged; Oligopeptides; Pyridines; Pyrrolidinones; Quinolones; Raltegravir Potassium; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load

2012

Other Studies

1 other study(ies) available for atazanavir sulfate and Diarrhea

Article	Year
Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women. Clinical pharmacology and therapeutics, 2020, Volume: 107, Issue:2 Topics: Area Under Curve; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B; Chromatography, High Pressure Liquid; Citrus sinensis; Cytochrome P-450 CYP3A Inhibitors; Diarrhea; Dose-Response Relationship, Drug; Female; Genotype; Hair; Heroin Dependence; HIV Infections; HIV Protease Inhibitors; Humans; Hydrogen-Ion Concentration; Longitudinal Studies; MicroRNAs; Polymorphism, Single Nucleotide; Racial Groups; Receptors, Cell Surface; Tandem Mass Spectrometry	2020

Article

Year

Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women.

Clinical pharmacology and therapeutics, 2020, Volume: 107, Issue:2

Topics: Area Under Curve; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B; Chromatography, High Pressure Liquid; Citrus sinensis; Cytochrome P-450 CYP3A Inhibitors; Diarrhea; Dose-Response Relationship, Drug; Female; Genotype; Hair; Heroin Dependence; HIV Infections; HIV Protease Inhibitors; Humans; Hydrogen-Ion Concentration; Longitudinal Studies; MicroRNAs; Polymorphism, Single Nucleotide; Racial Groups; Receptors, Cell Surface; Tandem Mass Spectrometry

2020